A Genetic Key to Myelination, Forged in Thin Air
A recent study in *Neuron* reveals a genetic variant in the *Retsat* gene, associated with high-altitude adaptation, that promotes myelination through a novel signaling pathway. The gain-of-function variant boosts neuronal synthesis of a metabolite called ATDRA, which then activates the RXR-γ receptor in oligodendrocyte progenitor cells, driving them to produce the myelin sheath that insulates nerve fibers. This discovery not only links human evolutionary genetics to fundamental neurodevelopmental processes but also demonstrates therapeutic potential, as administering the prodrug ATDR successfully promoted remyelination in models of myelin disease.
Study Significance: This research directly connects human population genetics and evolutionary selection pressures with a precise molecular mechanism for brain development, offering a new target for gene therapy and drug development in demyelinating disorders like multiple sclerosis. For professionals in genetics and genomics, it underscores how studying natural human genetic diversity and adaptation can uncover novel pathways with significant therapeutic implications, moving beyond traditional disease-associated variants to functional, beneficial alleles.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
